Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion

Sarah K Whiteside1, Francis M Grant2, Giorgia Alvisi3

  • 1Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK.

Science Immunology
|December 15, 2023
PubMed

Insights

Depleting regulatory T (Treg) cells to fight cancer can backfire. Conventional T (Tconv) cells gain suppressive abilities, hindering therapy. Targeting IL-10 signaling alongside Treg depletion may improve cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Immunotherapy

Background:

  • Regulatory T (Treg) cells maintain immune homeostasis but suppress anti-cancer immune responses.
  • Current Treg cell-targeted cancer immunotherapies show limited success due to poorly understood resistance mechanisms.

Purpose of the Study:

  • To investigate the mechanisms underlying therapeutic failure in Treg cell-targeted cancer immunotherapy.
  • To identify alternative immunosuppressive pathways activated upon Treg cell depletion.

Main Methods:

  • Mouse models of Treg cell-targeted immunotherapy.
  • Analysis of T cell populations, gene expression (transcriptional profiling), and suppressive function ex vivo.
  • Assessment of IL-10's role in immunosuppression and therapeutic efficacy.
  • In vivo studies involving conditional gene deletion (Il10) and antibody blockade of IL-10 signaling.

Main Results:

  • Depletion of Treg cells induced suppressive function in CD4+ Foxp3- conventional T (Tconv) cells.
  • Tumor-infiltrating Foxp3- Tconv cells adopted a Treg-like transcriptional profile and suppressed T cell activity.
  • CD4+ Tconv cells expressing C-C motif receptor 8 (CCR8) were identified as a key suppressive population in tumors.
  • CCR8+ Tconv cells expanded systemically and intratumorally upon Treg cell depletion, mediating IL-10-dependent immunosuppression.
  • Conditional deletion of IL-10 in T cells or IL-10 signaling blockade synergized with Treg cell depletion to enhance anti-tumor immunity.

Conclusions:

  • Conventional T cells can acquire immunosuppressive functions upon Treg cell depletion, representing a novel mechanism of therapeutic resistance.
  • CCR8+ Tconv cells are a critical mediator of this secondary immunosuppression.
  • Targeting IL-10 signaling in conjunction with Treg cell depletion offers a promising strategy to overcome treatment resistance in cancer immunotherapy.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
68.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
741
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K